1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6166EC5C0C4DBD43985256BA400539171
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/coordinating-professional-and-advocacy-relations-efforts-for-maximum-return?opendocument
18
19opendocument
2044.200.122.214
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Patient Advocacy

Coordinating Professional and Advocacy Relations Efforts for Maximum Return

DB Image

ID: 4262


Features:

Graphics


Words: 4,549


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Pharmaceutical companies must be in direct contact with the healthcare sector if their product is going to be successful. By reaching professional groups, companies make connections with physicians, pharmacists and others in the allied healthcare fields. Companies can use this 17-page document to examine best practices in coordinating Professional and Advocacy Relations (PAR) efforts, including prioritizing professional and advocacy groups and building buy-in for activities at the brand-team level.


Some of the key topics covered are
--Group Ranking

--Setting Internal Priorities
--Determining Activity Value

This research originated from a Best Practices, LLC consulting project.


Industries Profiled:
Pharmaceutical; Biotech; Health Care; Medical Device


Companies Profiled:
AstraZeneca Pharmaceuticals; Pfizer; Novartis; Roche; Abbott Laboratories; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Merck

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.